Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_provenance.
- NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_assertion description "[We selected ER-positive tumors, and clinical end points for the HOXB13-to-IL17BR ratio were disease-free survival (DFS) in patients with primary breast cancer (N = 619) and progression-free survival (PFS) in patients with recurrent breast cancer treated with first-line tamoxifen monotherapy (N = 193).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_provenance.
- NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_assertion evidence source_evidence_literature NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_provenance.
- NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_assertion SIO_000772 17308270 NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_provenance.
- NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_assertion wasDerivedFrom befree-2016 NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_provenance.
- NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_assertion wasGeneratedBy ECO_0000203 NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_provenance.
- befree-2016 importedOn "2016-02-19" NP594607.RAdRcKbjSMY_vRfg8bk8x_2diMzD_l1KEnx4VCrv3KnVA130_provenance.